Edition:
United States

Challenger Ltd (CGF.AX)

CGF.AX on Australia Stock Exchange

12.93AUD
29 May 2017
Change (% chg)

$-0.23 (-1.75%)
Prev Close
$13.16
Open
$13.20
Day's High
$13.21
Day's Low
$12.91
Volume
1,032,588
Avg. Vol
1,677,956
52-wk High
$13.73
52-wk Low
$8.13

Latest Key Developments (Source: Significant Developments)

Challenger reconfirms FY17 Life COE guidance
Monday, 22 May 2017 07:54pm EDT 

May 23 (Reuters) - Challenger Ltd :Reconfirms FY17 life COE guidance – mid-point of $620m to $640m range.  Full Article

Challenger Ltd announces total group assets and funds under management as at March 31
Wednesday, 19 Apr 2017 09:17pm EDT 

April 20 (Reuters) - Challenger Ltd :Challenger's total group assets and funds under management at 31 march 2017 was $66.6 billion, up 3% for quarter.FY17 life coe expected to be mid-point of $620 million to $640 million guidance range.Annuity sales increased by 53% on prior corresponding period (pcp), with particularly strong growth in lifetime annuities.For 2017 FY, expects life's normalised cash operating earnings to be around mid-point of its $620 million- $640 million guidance range.  Full Article

Challenger Ltd capital notes 2 offer offer increased
Wednesday, 1 Mar 2017 12:53am EST 

Challenger Ltd :Capital notes 2 offer offer has been increased from $350 million to an expected $450 million.  Full Article

Challenger Ltd updates on guidance
Wednesday, 26 Oct 2016 09:03pm EDT 

Challenger Ltd :"reaffirm life's 2017 cash operating earnings guidance range of $620 million to $640 million".  Full Article

Challenger Ltd updates on guidance
Wednesday, 26 Oct 2016 04:38pm EDT 

Challenger Ltd :"reaffirm life's 2017 cash operating earnings guidance range of $620 million to $640 million".  Full Article

Challenger says FY revenue from ordinary activities $1.81 bln vs $1.69 bln
Monday, 15 Aug 2016 06:30pm EDT 

Challenger Ltd : Appendix 4e 2016 . FY net profit for the year attributable to equity holders $327.7 million versus $299 million . Final per ordinary share - 100% franked 16.5 cents . Says FY revenue from ordinary activities $ 1.81 billion versus $1.69 billion . In terms of our financial targets for FY 2017, life normalised coe guidance is a range of $620 million to $640 million" . Full year dividend of 32.5 cents up 8% . Expects to maintain a fully franked dividend payout ratio of 45% to 50% of normalised profit, subject to prevailing market conditions" . Continues to target normalised return on equity of 18% pre-tax" . In terms of our financial targets for FY 2017, life normalised coe guidance is a range of $620 million to $640 million" .  Full Article

Challenger Limited to pay ordinary dividend
Friday, 28 Aug 2015 01:01am EDT 

Challenger Limited:Says ordinary fully paid dividend of A$0.97000000 per share.Record date is on Nov 17.Payment date is on Nov 25.  Full Article

Challenger Limited says funds management division Fidante Partners acquires Dexion Capital
Tuesday, 14 Jul 2015 06:29pm EDT 

Challenger Limited:Fidante partners acquires investments group dexion capital.Says "acquisition substantially expands fidante partners' presence in Europe".Says Challenger will make an agreed fixed payment of A$41 million to dexion's shareholders.Says acquisition is immediately earnings accretive and is expected to meet challenger's 18% pre-tax return on equity target.Says completion is expected to occur in July 2015.Fidante Partners is Challenger Limited's boutique funds management division.  Full Article

Challenger Ltd sells KLpstream equity interest and enters new distribution and service agreements with Kapstream and Janus
Wednesday, 1 Jul 2015 06:26pm EDT 

Challenger Ltd:Says sale of its 25 pct equity interest in Australian based global fixed income fund manager, Kapstream Capital Pty Limited (Kapstream), to Janus Capital Group Inc. (Janus) for $45 mln.Sale provides opportunities to further develop Kapstream and Challenger’s Fidante Partners businesses.  Full Article

More From Around the Web

BRIEF-Challenger reconfirms FY17 Life COE guidance

* Reconfirms FY17 life COE guidance – mid-point of $620m to $640m range Source text for Eikon: Further company coverage: